PUBLISHER: Azoth Analytics | PRODUCT CODE: 1390400
PUBLISHER: Azoth Analytics | PRODUCT CODE: 1390400
Azoth Analytics has released a research report titled "Global Latent TB Testing Market (2023 Edition)" which provides a complete analysis of the Global Latent TB Testing industry in terms of market segmentation By Test Type (Tuberculin Skin Test -TST, Interferon Gamma Released Assay -IGRA), By End User (Diagnostic Laboratories, Hospitals and Clinics, Academic and Research Institute), By Region (Americas, Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, China, Japan, India, South Korea, Australia). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.
The Global Latent TB Testing Market is expected to generate USD 3.93 Billion by the end of 2029, up from USD 1.8 Billion in 2022. A favourable growth element for the global Latent TB Testing market is propelled by government initiatives and policies, raising awareness and education, and technological advancements in testing methods. During the forecast period, 2024-2029, Global Latent TB Testing is expected to expand at a CAGR of 12%. The prevalence of TB, especially in high-burden regions, drives the need for effective latent TB testing. As TB remains a global health concern, early detection and management of latent infections become critical for disease control.
According to the National Library of Medicine, "one-third" of the world's population, or roughly 2.3 billion people, have LTBI. The WHO estimates that approximately 2 billion people, or more than one-third of the global total, are TB carriers. A high prevalence of latent TB indicates a larger pool of individuals at risk of developing active TB. Latent TB testing becomes essential for identifying those with latent infections, allowing for early intervention and preventive measures.
Technological advancements contribute to the improvement of latent TB testing methods, making them more reliable, convenient, and suitable for diverse healthcare settings. Continued research and innovation in the field are expected to further enhance the accuracy and accessibility of latent TB testing in the future.
The development of next-generation interferon-gamma release assays (IGRAs), such as the QuantiFERON-TB Gold Plus, represents an improvement over earlier versions. These assays offer enhanced sensitivity and specificity in detecting latent TB infections, reducing the likelihood of false-positive results.
Quality assurance and standardization in diagnostic laboratories are gaining prominence. Adherence to international quality standards and the establishment of standardized testing protocols are essential for ensuring the reliability and comparability of latent TB test results. Laboratories are focusing on maintaining high-quality testing procedures. Ongoing R&D efforts lead to the development of improved testing technologies, such as next-generation assays and advanced molecular diagnostic methods. These technologies often offer enhanced sensitivity, specificity, and faster turnaround times, improving the overall efficiency of latent TB testing.
Scope of the Report:
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A3: United States Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A4: United States Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A5: United States Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A6: Canada Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A7: Canada Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A8: Canada Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A9: Canada Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A10: Rest of Americas Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A11: Rest of Americas Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A12: Rest of Americas Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A13: Rest of Americas Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A14: Germany Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A15: Germany Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A16: Germany Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A17: Germany Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A18: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A19: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A20: United Kingdom Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A21: United Kingdom Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A22: France Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A23: France Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A24: France Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A25: France Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A26: Rest of Europe Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A27: Rest of Europe Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A28: Rest of Europe Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A29: Rest of Europe Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A30: China Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A31: China Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A32: China Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A33: China Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A34: Japan Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A35: Japan Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A36: Japan Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A37: Japan Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A38: India Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A39: India Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A40: India Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A41: India Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A42: South Korea Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A43: South Korea Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A44: South Korea Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A45: South Korea Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A46: Australia Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A47: Australia Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A48: Australia Latent TB Testing Market, By End User, By Value, 2019-2022 (USD Million)
Table A49: Australia Latent TB Testing Market, By End User, By Value, 2023-2029 (USD Million)
Table A50: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2019-2022 (USD Million)
Table A51: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2023-2029 (USD Million)
Table A52: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2019-2022 (USD Million)
Table A53: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2023-2029 (USD Million)
Table A54: Qiagen Key Company Financials, 2020-2022
Table A55: Sanofi Key Financials, 2020-2022
Table A56: Abbott Laboratories Key Financials, 2020-2022
Table A57: Roche Key Financials, 2020-2022
Table A58: Bio-Rad Laboratories Key Company Financials, 2020-2022
Table A59: BioMerieux Key Company Financials, 2020-2022
Table A60: Becton Dickinson and Co Key Company Financials, 2020-2022